乳腺癌分子分型的临床病理表现分析  

Analysis on Clinical Pathological Manifestation of the Molecular Typing of Breast Cancer

作　　者：童晶 丁岚[1] 

机构地区：[1]扬州市江都人民医院病理科,江苏扬州225200

出　　处：《中国继续医学教育》2018年第7期54-56,共3页China Continuing Medical Education

摘　　要：目的探讨乳腺癌不同分子分型的临床病理表现,为疾病诊治提供参考。方法回顾性分析2016年1月—2017年12月我院收治的124例乳腺癌患者的临床资料,观察患者乳腺癌分子分型情况及不同分子分型的临床病理特征。结果患者中,管腔A型39.52%,管腔B型30.65%,Her-2亚型12.90%,基底亚型13.71%。分子分型同肿瘤大小、腋窝淋巴结转移状况及TNM分期差异有统计学意义(P<0.05)。结论乳腺癌分子分型能够为乳腺癌临床诊治及预后评估提供有价值的依据。Objective To analyze the clinical pathological features of different molecular types of breast cancer, to provide reference for clinical diagnosis and treatment. Methods The clinical data of 124 patients with breast cancer in our hospital from January 2016 to December 2017 were retrospectively analyzed. The molecular typing of breast cancer and clinical pathological characteristics of different molecular typing were observed. Results In the patients, the lumen A type accounted for 39.52%, the lumen B type accounted for 30.65%, the Her-2 subtype accounted for 12.90%,and the basal subtype accounted for 13.71%. The molecular typing was signifcantly different from the tumor size, axillary lymph node metastasis and TNM staging （P 〈 0.05）. Conclusion The molecular classifcation of breast cancer can provide a valuable basis for the diagnosis and treatment of breast cancer and the prognosis evaluation.

关 键 词：乳腺癌 分子分型 临床病理 特征 

分 类 号：R493[医药卫生—康复医学]